Cytochrome P450-derived eicosanoids and vascular dysfunction in coronary artery disease patients.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Atherosclerosis

• Publication date

  2013-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.atherosclerosis.2013.01.034PMID 23466098PMCID PMC3638946
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inflammation, Atherosclerosis and Coronary Artery Disease

  2014cited by this paper
• Soluble epoxide hydrolase regulates hematopoietic progenitor cell function via generation of fatty acid diols

  2012cited by this paper
• Pharmacokinetics and Pharmacodynamics of AR9281, an Inhibitor of Soluble Epoxide Hydrolase, in Single‐ and Multiple‐Dose Studies in Healthy Human Subjects

  2012cited by this paper
• The Assessment of Endothelial Function: From Research Into Clinical Practice

  2012cited by this paper
• Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease.

  2012influential reference
• Relation between digital peripheral arterial tonometry and brachial artery ultrasound measures of vascular function in patients with coronary artery disease and in healthy volunteers.

  2012cited by this paper
• Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia‐reperfusion injury in isolated mouse heart

  2011cited by this paper
• Genetic Variation in Soluble Epoxide Hydrolase (EPHX2) Is Associated With Forearm Vasodilator Responses in Humans

  2011cited by this paper
• Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice

  2011cited by this paper
• Endogenous Epoxygenases Are Modulators of Monocyte/Macrophage Activity

  2011cited by this paper
• Age as a Modulator of Inflammatory Cardiovascular Risk Factors

  2011cited by this paper
• 20-Hydroxyeicosatetraeonic Acid: A New Target for the Treatment of Hypertension

  2010cited by this paper
• 20-Hydroxy-5,8,11,14-eicosatetraenoic Acid Mediates Endothelial Dysfunction via IκB Kinase-Dependent Endothelial Nitric-Oxide Synthase Uncoupling

  2010cited by this paper
• Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation.

  2010cited by this paper
• Lipidomics reveals a remarkable diversity of lipids in human plasma1[S]

  2010cited by this paper
• Overexpression of cytochrome P450 4F2 in mice increases 20-hydroxyeicosatetraenoic acid production and arterial blood pressure.

  2009cited by this paper
• Inhibition of soluble epoxide hydrolase attenuated atherosclerosis, abdominal aortic aneurysm formation and dyslipidemia in apolipoprotein E deficient mice infused with angiotensin II

  2009cited by this paper
• Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease.

  2009cited by this paper
• Endothelial Dysfunction: Associations with Exposure to Ambient Fine Particles in Diabetic Individuals

  2008cited by this paper
• Inhibition of Soluble Epoxide Hydrolase Does Not Protect against Endotoxin-Mediated Hepatic Inflammation

  2008cited by this paper
• Hydrogen Peroxide Inhibits Cytochrome P450 Epoxygenases: Interaction Between Two Endothelium-Derived Hyperpolarizing Factors

  2008cited by this paper
• Epithelial Neutrophil-Activating Peptide (ENA-78), Acute Coronary Syndrome Prognosis, and Modulatory Effect of Statins

  2008cited by this paper
• A Single Nucleotide Polymorphism in the CYP4F2 but not CYP4A11 Gene Is Associated With Increased 20-HETE Excretion and Blood Pressure

  2008cited by this paper
• 20-Hydroxyeicosatetraenoic Acid Stimulates Nuclear Factor-κB Activation and the Production of Inflammatory Cytokines in Human Endothelial Cells

  2008cited by this paper
• Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial.

  2007cited by this paper
• Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation.

  2006cited by this paper
• Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study.

  2006cited by this paper
• Role of Soluble Epoxide Hydrolase in Postischemic Recovery of Heart Contractile Function

  2006cited by this paper
• C-reactive protein levels and outcomes after statin therapy.

  2005cited by this paper
• Inflammation, atherosclerosis, and coronary artery disease.

  2005cited by this paper
• Inhibition of Cytochrome P450 2C9 Improves Endothelium-Dependent, Nitric Oxide–Mediated Vasodilatation in Patients With Coronary Artery Disease

  2004cited by this paper
• Urinary 20-Hydroxyeicosatetraenoic Acid Is Associated With Endothelial Dysfunction in Humans

  2004cited by this paper
• Risk of Coronary Artery Disease Associated With Polymorphism of the Cytochrome P450 Epoxygenase CYP2J2

  2004cited by this paper
• Statistical significance for genomewide studies

  2003cited by this paper
• P-450 metabolites of arachidonic acid in the control of cardiovascular function.

  2002cited by this paper
• C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.

  2001cited by this paper
• Circulating Cell Adhesion Molecules and Death in Patients With Coronary Artery Disease

  2001cited by this paper
• Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.

  1999cited by this paper
• Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects.

  1997cited by this paper

• The Role of Arachidonic Acid Metabolizing Cytochromes P450 in the Control of Cardiovascular Functions

  2024cites this paper
• Cytochrome P450-derived Epoxyeicosatrienoic Acid, the Regulation of Cardiovascular-related Diseases, and the Implication for Pulmonary Hypertension

  2024cites this paper
• The Synergistic and Opposing Roles of ω-Fatty Acid Hydroxylase (CYP4A11) and ω-1 Fatty Acid Hydroxylase (CYP2E1) in Chronic Liver Disease

  2024cites this paper
• Genetic analyses of circulating PUFA-derived mediators identifies heritable dihydroxyeicosatrienoic acid species.

  2022cites this paper
• Differential Contribution of Renal Cytochrome P450 Enzymes to Kidney Endothelial Dysfunction and Vascular Oxidative Stress in Obesity.

  2021cites this paper
• Coronary Large Conductance Ca2+-Activated K+ Channel Dysfunction in Diabetes Mellitus

  2021cites this paper
• Excess ischemic tachyarrhythmias trigger protection against myocardial infarction in hypertensive rats.

  2021cites this paper
• Association of Arachidonic Acid-derived Lipid Mediators with Subsequent Onset of Acute Myocardial Infarction in Patients with Coronary Artery Disease

  2020cites this paper
• Metabolomics reveal dynamic changes in eicosanoid profile in patients with ST‐elevation myocardial infarction after percutaneous coronary intervention

  2020cites this paper
• Higher Epoxyeicosatrienoic Acids in Cardiomyocytes-Specific CYP2J2 Transgenic Mice Are Associated with Improved Myocardial Remodeling

  2020cites this paper
• Vascular Lipidomic Profiling of Potential Endogenous Fatty Acid PPAR Ligands Reveals the Coronary Artery as Major Producer of CYP450-Derived Epoxy Fatty Acids

  2020cites this paper
• Ibuprofen alters epoxide hydrolase activity and epoxy-oxylipin metabolites associated with different metabolic pathways in murine livers

  2020cites this paper
• Epoxyeicosatrienoic acid analog EET-B attenuates post-myocardial infarction remodeling in spontaneously hypertensive rats

  2019cites this paper
• Activation of Lipid Mediator Formation Due to Lipoprotein Apheresis

  2019cites this paper
• Lipidomic methodologies for biomarkers of chronic inflammation in nutritional research: ω-3 and ω-6 lipid mediators.

  2019cites this paper
• Omega-3 and omega-6 polyunsaturated fatty acids: Dietary sources, metabolism, and significance - A review.

  2018cites this paper
• Furthering the understanding of the redox control of soluble epoxide hydrolase and protein kinase G in the cardiovascular system

  2018cites this paper
• Regulation of CYP2J2 and EET Levels in Cardiac Disease and Diabetes

  2018cites this paper
• 20‐HETE in the regulation of vascular and cardiac function

  2018cites this paper
• Lipidomic profiling of targeted oxylipins with ultra-performance liquid chromatography-tandem mass spectrometry

  2018cites this paper
• An overview of the biologic effects of omega-6 oxylipins in humans.

  2018cites this paper
• EET Intervention on HO-1 Prevent Obesity Derived Cardiovascular Diseases

  2018cites this paper
• A Novel Polymorphism in the Promoter of the CYP4A11 Gene Is Associated with Susceptibility to Coronary Artery Disease

  2018cites this paper
• Increased epoxyeicosatrienoic acids may be part of a protective mechanism in human ulcerative colitis, with increased CYP2J2 and reduced soluble epoxide hydrolase expression.

  2018cites this paper
• Urinary 11-dehydro-thromboxane B2 levels are associated with vascular inflammation and prognosis in atherosclerotic cardiovascular disease.

  2018cites this paper
• The Physiopathology of Cardiorenal Syndrome: A Review of the Potential Contributions of Inflammation

  2017cites this paper
• Altered Protein Expression of Cardiac CYP2J and Hepatic CYP2C, CYP4A, and CYP4F in a Mouse Model of Type II Diabetes—A Link in the Onset and Development of Cardiovascular Disease?

  2017cites this paper
• A rapid UPLC-MS/MS assay for eicosanoids in human plasma: Application to evaluate niacin responsivity.

  2017cites this paper
• Highly sensitive and specific derivatization strategy to profile and quantitate eicosanoids by UPLC-MS/MS.

  2017cites this paper
• Recent developments on the vascular effects of 20-hydroxyeicosatetraenoic acid

  2016cites this paper
• Epoxyeicosatrienoic acid analog attenuates the development of malignant hypertension, but does not reverse it once established: a study in Cyp1a1-Ren-2 transgenic rats

  2016cites this paper
• Epoxyeicosatrienoic Acid as Therapy for Diabetic and Ischemic Cardiomyopathy.

  2016cites this paper
• Aspirin inhibits the production of proangiogenic 15(S)-HETE by platelet cyclooxygenase-1

  2016cites this paper
• 20-Hydroxyeicosatetraenoic Acid (20-HETE) Modulates Canonical Transient Receptor Potential-6 (TRPC6) Channels in Podocytes

  2016cites this paper
• Cytochrome P450 genes in coronary artery diseases: Codon usage analysis reveals genomic GC adaptation.

  2016cites this paper
• 20-HETE and CYP4A2 ω-hydroxylase contribute to the elevated blood pressure in hyperandrogenemic female rats.

  2016cites this paper
• Effect of Subtotal Renal Nephrectomy on CYP450-Mediated Metabolism of Arachidonic Acid: A Potential Player in Pathogenesis of Renocardiac Syndrome?

  2016cites this paper
• Molecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology.

  2016cites this paper
• Fatty Acids and Cardiac Ischemia Reperfusion Injury

  2016cites this paper
• Cytochrome P450-derived epoxyeicosatrienoic acids and coronary artery disease in humans: a targeted metabolomics study[S]

  2016cites this paper
• The role of epoxyeicosatrienoic acids in the cardiovascular system

  2015cites this paper
• Cytochrome P450-Derived Lipid Mediators and Vascular Responses

  2015cites this paper
• TRANSLATIONAL APPROACHES TO UNDERSTANDING THE ROLE OF CYTOCHROME P450-DERIVED EPOXYEICOSATRIENOIC ACIDS IN CORONARY ARTERY DISEASE

  2015cites this paper
• Vascular actions of 20-HETE.

  2015cites this paper
• Role of Cytochrome P450s in Inflammation.

  2015cites this paper
• Prostaglandins and Other Lipid Mediators eview ascular actions of 20-HETE amantha

  2015cites this paper
• Effects of short-term walnut consumption on human microvascular function and its relationship to plasma epoxide content.

  2015cites this paper
• A 3’-UTR Polymorphism in Soluble Epoxide Hydrolase Gene Is Associated with Acute Rejection in Renal Transplant Recipients

  2015cites this paper
• Effects of Angiotensin II Receptor Blockers on Metabolism of Arachidonic Acid via CYP2C8.

  2015cites this paper
• Aberrant Soluble Epoxide Hydrolase and Oxylipin Levels in a Porcine Arteriovenous Graft Stenosis Model

  2014cites this paper
• PHARMREV007781 1106..1140

  2014cites this paper
• The Cytochrome P 450 Epoxygenase Pathway Regulates the Hepatic Inflammatory Response in Fatty Liver Disease

  2014cites this paper
• Epoxyeicosatrienoic acids and cardioprotection: the road to translation.

  2014cites this paper
• Liquid chromatography-tandem mass spectrometry for the analysis of eicosanoids and related lipids in human biological matrices: a review.

  2014cites this paper
• The Pharmacology of the Cytochrome P 450 Epoxygenase / Soluble Epoxide Hydrolase Axis in the Vasculature and Cardiovascular Disease

  2014cites this paper
• The association of Vitamin D levels, blood pressure, inflammation and depression in persons with coronary artery disease

  2014cites this paper
• The Pharmacology of the Cytochrome P450 Epoxygenase/Soluble Epoxide Hydrolase Axis in the Vasculature and Cardiovascular Disease

  2014cites this paper
• Modulation of cardiac cytochrome P450 in patients with heart failure

  2014cites this paper
• Vascular characterization of mice with endothelial expression of cytochrome P450 4F2

  2014cites this paper
• The Cytochrome P450 Epoxygenase Pathway Regulates the Hepatic Inflammatory Response in Fatty Liver Disease

  2014cites this paper
• 20-HETE induces remodeling of renal resistance arteries independent of blood pressure elevation in hypertension.

  2013cites this paper
• The role of 14,15-dihydroxyeicosatrienoic acid levels in inflammation and its relationship to lipoproteins

  2013cites this paper
• Oxidized fatty acid analysis by charge-switch derivatization, selected reaction monitoring, and accurate mass quantitation.

  2013cites this paper